Fox Run Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-46,264
Closed -$853K 1204
2025
Q2
$853K Sell
46,264
-13,426
-22% -$238K 0.14% 242
2025
Q1
$1.04M Buy
+59,690
New +$1.01M 0.16% 193
2024
Q2
Sell
-36,538
Closed -$540K 1040
2024
Q1
$540K Buy
+36,538
New +$506K 0.12% 343
2023
Q4
Sell
-21,961
Closed -$306K 989
2023
Q3
$306K Buy
+21,961
New +$281K 0.09% 442
2022
Q4
Sell
-19,793
Closed -$260K 852
2022
Q3
$260K Buy
+19,793
New +$292K 0.1% 399
2020
Q4
Sell
-10,444
Closed -$144K 277
2020
Q3
$144K Buy
+10,444
New +$153K 0.36% 144
2020
Q1
Sell
-10,123
Closed -$216K 325
2019
Q4
$216K Buy
+10,123
New +$227K 0.17% 307
2018
Q2
Sell
-18,018
Closed -$318K 884
2018
Q1
$318K Buy
+18,018
New +$318K 0.08% 473
2017
Q1
Sell
-8,200
Closed -$200K 726
2016
Q4
$200K Buy
+8,200
New +$188K 0.11% 434
2016
Q3
Sell
-16,800
Closed -$347K 663
2016
Q2
$347K Buy
+16,800
New +$350K 0.17% 235
2016
Q1
Sell
-12,800
Closed -$259K 534
2015
Q4
$259K Buy
+12,800
New +$270K 0.2% 219

Other funds holding SBRA

Fox Run Management's SBRA Position: Q3 2025 in Review

Fox Run Management sold out of Sabra Healthcare REIT (SBRA) in Q3 2025, closing a stake of 46,264 shares — an estimated $853K sold.

Fox Run Management first reported a position in SBRA in Q4 2015 and held it in 11 quarters. The position peaked at $1.04M in Q1 2025. 424 funds tracked by Wall St. Rank hold SBRA as of Q3 2025.

  • Fox Run Management reported no remaining Sabra Healthcare REIT position as of Q3 2025 after selling out during the quarter.
  • Fox Run Management sold 46,264 Sabra Healthcare REIT shares in Q3 2025, an estimated $853K.
  • Fox Run Management first reported a position in Sabra Healthcare REIT in Q4 2015 and held it in 11 quarters.
  • Fox Run Management's Sabra Healthcare REIT position peaked at $1.04M in Q1 2025.
  • 424 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2025.

Based on Fox Run Management's 13F filing for Q3 2025, filed 12 Nov 2025.